|
 Taxotere Plus Avastin: Antiangiogenic Proof of Principle (2008),
Robert L. Leibowitz, MD
Treatment
of
Localized Prostate Cancer With Intermittent Triple Androgen Blockade:
Preliminary Results in 110 Consecutive Patients (2001),
Robert L. Leibowitz, MD et al.
Triple
Hormone
Blockade® Update: The Demise of the (Fool's) Gold Standard; The
Rise of the "Platinum and Diamond Standard”; Peer Recognition
from the
Multidisciplinary Prostate Cancer Conference, Orlando, Florida,
February 2005, and the First International Conference on IAB, London,
England, March 2005 (last updated 6/12/2008; originally written 02/2006), Robert L. Leibowitz, MD
Potpourri of Prostate Pearls and Insights
(2007),
Robert L. Leibowitz, MD
LEUKINE
(GM-CSF) and REVLIMID,
the Second Generation THALIDOMIDE Product (updated 2/4/2008; originally written 09/2006), Robert
L. Leibowitz, MD
Interferon
and Anti-angiogenesis
(6/2007),
Robert L. Leibowitz, MD
TRT
Case Reports:
High-Dose Testosterone Replacement Therapy (TRT) and Prostate Cancer
(CaP) (updated 03/2007), Robert L. Leibowitz, MD
Hormone
Refractory Prostate Cancer
(08/2004), Robert L. Leibowitz, MD
High-Dose
Testosterone
Replacement Therapy and Prostate Cancer (11/2006), Robert L.
Leibowitz, MD
Hormone
Blockade; Continuous,
Intermittent, or ? formerly, "Dr. Bob's Approach," (03/06),
Robert L.
Leibowitz, MD
Soy
and Prostate Cancer
(10/2007),
Robert L. Leibowitz, MD
Bisphosphonates
and
Osteonecrosis of the Maxilla and/or Mandible (Jaw Bones)
(10/2005), Robert L. Leibowitz, MD
Aredia
Monotherapy to Control
Metastatic, Hormone Refractory Prostate Cancer for more than Six Years
(11/2006), Robert L. Leibowitz, MD
Celebrex,
and Anti-Cancer Activity (02/2007), Robert L. Leibowitz, MD
Proscar
Greetings On
Father's Day: 2008 Update
(last updated 6/25/08; originally written 06/1997), Robert L. Leibowitz, MD
"PCAAC"
Prostate Cancer
Antiangiogenic Cocktail (09/2002), Robert L. Leibowitz, MD
I Am
The Only One You Are
Afraid To Believe (01/1999), Robert L. Leibowitz, MD
The
Emperor's New Clothes or
"The Platinum And Diamond Standard" (04/2004), Robert L.
Leibowitz, MD
Intermittent
Androgen Blockade
(Formerly "The Future Is Now!!" - Part II) (04/2004), Robert
L. Leibowitz, MD et al.
Dr.
Bob's
Recommended Vitamin List (10/2005), Robert L. Leibowitz, MD
High-Dose
Testosterone Replacement
Therapy (06/2004), Robert L. Leibowitz, MD et al.
Prostate
"Pearls" (04/2004), Robert L. Leibowitz, MD
Early
Hormonal Therapy
Works Ridiculously Well (10/2003), Robert L. Leibowitz, MD
The
Will Rogers Phenomenon
(04/2004), Robert L. Leibowitz, MD
Testosterone
Levels And Prostate
Cancer -- The Higher, The Better? (01/2003), Robert L.
Leibowitz, MD
Testosterone
ASCO Abstract (Phase I trial of exogenous testosterone (T) for the
treatment of castrate metastatic prostate cancer (PC) –
Morris MJ et. al. (6/2004)), Discussion by Robert L.
Leibowitz, MD 05/2004
Celebrex,
a Cox-2 Inhibtor: Off Label Use for Treating Prostate and Other
Cancers (12/2006), Robert L. Leibowitz, MD
"The
Facts, Doc, Just The
Facts" (04/2004), Robert L. Leibowitz, MD et al.
The
Capitulation Of
Radiation Therapy Has Begun (04/2004), Robert L. Leibowitz, MD
Dawning
Of The Age Of
Angiogenesis (04/2004), Robert L. Leibowitz, MD
Hormone
Blockade Versus Radical
Local Therapies - And The Winner Is.... (11/2002), Robert L.
Leibowitz, MD
Angiostatin
And Why Local
Therapy Fails To Cure So Many Men (Formerly "The Transitional Zone Era")
(04/2004), Robert L. Leibowitz, MD
December
2001
National Cancer
Institute Article (Treatment Options) (01/2002), Robert L.
Leibowitz, MD
The
Risk of Thrombosis
(Blood Clots) with the use of Thalidomide and/or Revlimid
(02/2007), Robert L. Leibowitz, MD
Statin
Drugs and Advanced
Risk of Prostate Cancer (01/2007), Robert L. Leibowitz, MD
|
